74 related articles for article (PubMed ID: 20730882)
21. Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report.
Berger M; Ferrero I; Vassallo E; Gastaldo L; Carraro F; Biasin E; Madon E; Fagioli F
Pediatr Hematol Oncol; 2005; 22(7):597-608. PubMed ID: 16166053
[TBL] [Abstract][Full Text] [Related]
22. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
23. [Functional analysis of notch in the pathophysiology of leukemia].
Tohda S
Rinsho Byori; 2009 Apr; 57(4):351-6. PubMed ID: 19489437
[TBL] [Abstract][Full Text] [Related]
24. [Early relapse after peripheral blood stem cell transplantation in acute myelogenous leukemia with t(8;21)].
Fukumoto Y; Tanizawa A; Takeuchi M; Takano T; Kikawa Y; Sudo M
Rinsho Ketsueki; 1995 Oct; 36(10):1204-9. PubMed ID: 8531332
[TBL] [Abstract][Full Text] [Related]
25. Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
Mele A; Leopardi G; Sparaventi G; Nicolini G; D'Adamo F; Guiducci B; Barulli S; Malerba L; Stramigioli S; Talevi N; Politi P; Isidori A; Malagola M; Piccaluga P; Visani G
Eur J Haematol; 2005 Apr; 74(4):277-81. PubMed ID: 15777338
[TBL] [Abstract][Full Text] [Related]
26. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling for improved dissection of acute leukemia: a recently identified immature myeloid/T-lymphoid subgroup as an example.
Wouters BJ; Koss C; Delwel R
Blood Cells Mol Dis; 2008; 40(3):395-400. PubMed ID: 18096415
[TBL] [Abstract][Full Text] [Related]
29. Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia.
Ooi J; Takahashi S; Tomonari A; Tsukada N; Konuma T; Kato S; Kasahara S; Sato A; Monma F; Nagamura F; Iseki T; Tojo A; Asano S
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1341-7. PubMed ID: 19041055
[TBL] [Abstract][Full Text] [Related]
30. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
31. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
33. [Myocardial infiltration and formation of multiple granulocytic sarcoma of acute myeloid leukemia after cord blood transplantation].
Hagihara M; Motohashi K; Ohshima R; Ito S; Sakuma Y; Kameda Y; Maruta A; Ishigatsubo Y; Kanamori H
Rinsho Ketsueki; 2009 Jul; 50(7):574-6. PubMed ID: 19638726
[TBL] [Abstract][Full Text] [Related]
34. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
[TBL] [Abstract][Full Text] [Related]
35. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine-induced autologous graft-versus-host disease in patients with acute myeloid leukemia undergoing non-myeloablative chemotherapy without progenitor cell reinfusion.
Stein M; Feldman E; Seiter K; Chiao JW; Goff H; Baskind P; Beer M; Ahmed T
Bone Marrow Transplant; 1999 Nov; 24(10):1073-7. PubMed ID: 10578157
[TBL] [Abstract][Full Text] [Related]
37. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
Nishimura A; Yokoyama K; Naruto T; Yamagishi C; Imamura T; Nakazono H; Kimura S; Ito M; Sagisaka M; Tanaka Y; Piao J; Namikawa Y; Yanagimachi M; Isoda T; Kanai A; Matsui H; Isobe T; Sato-Otsubo A; Higuchi N; Takada A; Okuno H; Saito S; Karakawa S; Kobayashi S; Hasegawa D; Fujisaki H; Hasegawa D; Koike K; Koike T; Rai S; Umeda K; Sano H; Sekinaka Y; Ogawa A; Kinoshita A; Shiba N; Miki M; Kimura F; Nakayama H; Nakazawa Y; Taga T; Taki T; Adachi S; Manabe A; Koh K; Ishida Y; Takita J; Ishikawa F; Goto H; Morio T; Mizutani S; Tojo A; Takagi M
Sci Adv; 2023 Dec; 9(50):eadj4407. PubMed ID: 38091391
[TBL] [Abstract][Full Text] [Related]
38. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
